Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.38B 3.94B 503M 442M 418M 379M 712M 48.27B 717M 5.01B 1.93B 24.63B 1.89B 1.85B 79.15B P/E 2026 *
7.43x
P/E 2027 * 6.59x
Enterprise Value 3.38B 3.94B 503M 442M 418M 379M 712M 48.27B 717M 5.01B 1.93B 24.63B 1.89B 1.85B 79.15B EV / Sales 2026 *
0.48x
EV / Sales 2027 * 0.45x
Free-Float
45.7%
Yield 2026 *
6.07%
Yield 2027 * 6.83%
08-28 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
08-28 Tong Ren Tang Technologies Co. Ltd. Enters New E-Commerce Service Cooperation Framework Agreement with Beijing Tong Ren Tang Shuzi Technology Co., Ltd CI
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-26 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
1 day+1.79%
1 week+0.80%
Current month+6.09%
1 month+6.09%
3 months-2.94%
6 months-19.82%
Current year-28.91%
1 week 3.05
Extreme 3.05
3.2
1 month 2.96
Extreme 2.955
3.28
Current year 2.96
Extreme 2.955
4.56
1 year 2.96
Extreme 2.955
4.95
3 years 2.96
Extreme 2.955
7.03
5 years 2.96
Extreme 2.955
9.28
10 years 2.96
Extreme 2.955
16
Manager TitleAgeSince
Chief Executive Officer 58 2025-06-03
Comptroller/Controller/Auditor 48 2025-06-03
Corporate Secretary 37 2026-07-08
Director TitleAgeSince
Director/Board Member 67 2011-02-09
Director/Board Member 69 2018-06-11
Director/Board Member 82 2018-06-11
Change 5-day change 1-year change 3-year change Capi.($)
+1.79%+0.80%-34.00%-49.68% 505M
+0.92%-1.49%-11.87%-5.57% 13.26B
-0.04%-1.39%-31.78%-57.41% 4.77B
+0.29%-0.70%-4.83%-7.70% 4.29B
+0.07%-2.82%-4.17%-35.42% 3.77B
+0.14%-0.06%-19.70%-3.43% 3.48B
+1.02%-1.20%-0.88%-9.80% 3.35B
+0.88%-1.92%-12.16%-4.96% 3.04B
-0.34%-2.03%-20.76%-19.25% 2.24B
-0.46%-3.07%-25.72%-25.92% 1.64B
Average +0.43%-1.45%-16.59%-21.92% 4.03B
Weighted average by Cap. +0.48%-1.48%-13.87%-16.97%

Financials

2026 *2027 *
Net sales 6.98B 8.16B 1.04B 915M 865M 784M 1.47B 99.82B 1.48B 10.36B 4B 50.94B 3.9B 3.82B 164B 7.56B 8.84B 1.13B 991M 937M 850M 1.6B 108B 1.61B 11.22B 4.33B 55.18B 4.23B 4.14B 177B
Net income 454M 531M 67.7M 59.54M 56.3M 51.07M 95.9M 6.5B 96.46M 674M 260M 3.32B 254M 249M 10.66B 514M 600M 76.48M 67.27M 63.61M 57.69M 108M 7.34B 109M 762M 294M 3.75B 287M 281M 12.04B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,801
Date Price Change Volume
26-09-28 HK$3.135 +1.79% 344,000
26-09-28 HK$3.080 -0.32% 501,000
26-09-25 HK$3.090 -1.12% 702,000
26-09-24 HK$3.125 -0.16% 2,840,000
26-09-23 HK$3.130 +0.64% 796,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.636CNY
Average target price
4.601CNY
Spread / Average Target
+74.55%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock